Search - tctmd.com

Displaying 201 - 220 of 312

Sort: Relevancy | Date

Presentation TCT 2017

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques With Noninvasive Testing

Presenter: John A. Ambrose, Y. S. Chandrashekhar, James A. Goldstein

November 01, 2017

Podcast TCTMD Talking Points

COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting

October 18, 2017

Presentation ESC 2017

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Presenter: Paul M. Ridker

August 27, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

News Daily News

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Yael L. Maxwell

June 16, 2017

News Daily News

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

Michael O'Riordan

June 09, 2017

News Daily News

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Alison Palkhivala

May 23, 2017

News Conference News EuroPCR 2017

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Yael L. Maxwell

May 22, 2017

News Daily News

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

Caitlin E. Cox

May 15, 2017

News Conference News EAS 2017

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

Yael L. Maxwell

May 01, 2017

News Conference News ACC 2017

People Living in Amazon Rainforest Provide Clues to Coronary Protection

L.A. McKeown

March 17, 2017

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

TCT 548: Relationship Between Residual SYNTAX Score, Grayscale and Virtual Histology-IVUS Findings, and Non-Culprit Lesion-Related Major Adverse Cardiac Events: The PROSPECT Study

Presenter: Eric Boersma, James E. Muller

November 01, 2016

Presentation TCT 2016

TCT 599: Not All Plaque Ruptures Are Born Equal: An Optical Coherence Tomography Study

Presenter: Eric Boersma, James E. Muller

November 01, 2016

Presentation TCT 2016

TCT 598: Plaque Rupture in Coronary Atherosclerosis is Associated with Increased Plaque Structural Stress

Presenter: Eric Boersma, James E. Muller

November 01, 2016

Presentation TCT 2016

TCT 597: Why Does Thin-Cap Fibroatheroma Cluster in the Proximal egment in Left Anterior Coronary Artery, But Are Evenly Distributed Throughout the Entire Right Coronary Artery? Results from Computational Fluid Dynamics Simulation by CT-FFR

Presenter: Eric Boersma, James E. Muller

November 01, 2016

Presentation TCT 2016

My Top Predictions for the Next Decade of Vulnerable Plaque Research: Insights From a Soothsayer

Presenter: Gregg W. Stone, Ron Waksman, John A. Ambrose

November 01, 2016

Presentation TCT 2016

Put Away Your Catheters! Nanomedicines to Treat Vulnerable Plaque

Presenter: Gregg W. Stone, Ron Waksman, Jonathan Leor

November 01, 2016

Presentation TCT 2016

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

Presenter: Gregg W. Stone, Ron Waksman, Sanjit S. Jolly

November 01, 2016

Advertisement

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques With Noninvasive Testing

COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

People Living in Amazon Rainforest Provide Clues to Coronary Protection

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

TCT 548: Relationship Between Residual SYNTAX Score, Grayscale and Virtual Histology-IVUS Findings, and Non-Culprit Lesion-Related Major Adverse Cardiac Events: The PROSPECT Study

TCT 599: Not All Plaque Ruptures Are Born Equal: An Optical Coherence Tomography Study

TCT 598: Plaque Rupture in Coronary Atherosclerosis is Associated with Increased Plaque Structural Stress

TCT 597: Why Does Thin-Cap Fibroatheroma Cluster in the Proximal egment in Left Anterior Coronary Artery, But Are Evenly Distributed Throughout the Entire Right Coronary Artery? Results from Computational Fluid Dynamics Simulation by CT-FFR

My Top Predictions for the Next Decade of Vulnerable Plaque Research: Insights From a Soothsayer

Put Away Your Catheters! Nanomedicines to Treat Vulnerable Plaque

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content